Accessibility Menu
PureTech Health Plc Stock Quote

PureTech Health Plc (NASDAQ: PRTC)

$18.20
(1.1%)
+0.20
Price as of October 20, 2025, 3:22 p.m. ET

KEY DATA POINTS

Current Price
$18.2
Daily Change
(1.1%) +$0.20
Day's Range
$18.2 - $18.62
Previous Close
$18.2
Open
$18.62
Beta
0.61
Volume
-
Average Volume
3,991
Market Cap
443.7M
Market Cap / Employee
$18.36M
52wk Range
$13.3 - $24.99
Revenue
-
Gross Margin
0.46%
Dividend Yield
N/A
EPS
$1.77
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

PureTech Health Plc Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
PRTC-10.44%N/AN/A-53%
S&P+15.06%+95.03%+14.29%+86%

PureTech Health Plc Company Info

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

News & Analysis

Financial Health

General

No data available for this period.

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

No data available for this period.

Liabilities

No data available for this period.

Ratios

No data available for this period.

Cash Flow

No data available for this period.

Valuation

MetricYoY Change

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.